Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
VMD 
Viemed Healthcare Inc (VMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: VMD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 70.99% | Avg. Invested days 62 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 286.53M USD | Price to earnings Ratio 25.89 | 1Y Target Price 12.83 |
Price to earnings Ratio 25.89 | 1Y Target Price 12.83 | ||
Volume (30-day avg) 108823 | Beta 1.51 | 52 Weeks Range 6.21 - 9.81 | Updated Date 03/27/2025 |
52 Weeks Range 6.21 - 9.81 | Updated Date 03/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-04 | When After Market | Estimate 0.1 | Actual 0.1041 |
Profitability
Profit Margin 5.02% | Operating Margin (TTM) 8.83% |
Management Effectiveness
Return on Assets (TTM) 6.5% | Return on Equity (TTM) 9.23% |
Valuation
Trailing PE 25.89 | Forward PE 16.89 | Enterprise Value 273881649 | Price to Sales(TTM) 1.28 |
Enterprise Value 273881649 | Price to Sales(TTM) 1.28 | ||
Enterprise Value to Revenue 1.22 | Enterprise Value to EBITDA 6.47 | Shares Outstanding 39521600 | Shares Floating 34376694 |
Shares Outstanding 39521600 | Shares Floating 34376694 | ||
Percent Insiders 13 | Percent Institutions 64.98 |
Analyst Ratings
Rating 5 | Target Price 12.27 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Viemed Healthcare Inc
Company Overview
History and Background
Viemed Healthcare Inc. was founded in 2006. It provides in-home durable medical equipment (DME) and respiratory therapy services to patients in the United States, primarily focusing on chronic respiratory conditions. Over time, it has grown through organic expansion and strategic acquisitions.
Core Business Areas
- Respiratory Therapy Services: Provides in-home respiratory therapy and related equipment for patients with chronic obstructive pulmonary disease (COPD), asthma, and other respiratory illnesses.
- Durable Medical Equipment (DME): Supplies a range of DME, including ventilators, oxygen concentrators, and other devices needed for in-home respiratory care.
- Home Sleep Testing: Offers home sleep apnea testing services and related equipment.
Leadership and Structure
The leadership team consists of Casey Hoyt (CEO), Todd Trapp (COO), and David Haughton (CFO). The company operates with a geographically dispersed operational structure, managing services through regional teams.
Top Products and Market Share
Key Offerings
- Ventilators: Viemed provides ventilators for patients needing long-term respiratory support at home. Market share data specific to Viemed for ventilators is not readily available, but the overall home ventilator market is competitive. Competitors include ResMed, Philips Respironics, and Lincare.
- Oxygen Concentrators: Viemed supplies oxygen concentrators for patients needing supplemental oxygen. Competitors include Inogen, Invacare, and Philips Respironics.
- Home Sleep Testing devices: Viemed provides home sleep apnea testing devices. Market share data is not readily available. Competitors include ResMed, Philips Respironics, and Itamar Medical.
Market Dynamics
Industry Overview
The home healthcare industry is growing due to an aging population, increasing prevalence of chronic diseases, and a shift towards more cost-effective care settings. The respiratory care segment is particularly driven by the increasing incidence of COPD and other respiratory illnesses.
Positioning
Viemed is positioned as a provider of comprehensive in-home respiratory care services, focusing on improving patient outcomes and reducing hospital readmissions. Its competitive advantage lies in its expertise in respiratory therapy and its ability to provide coordinated care.
Total Addressable Market (TAM)
The estimated TAM for home respiratory care is expected to reach billions of dollars, with increasing market size year-over-year. Viemed captures a portion of this market by providing therapy services.
Upturn SWOT Analysis
Strengths
- Specialized expertise in respiratory care
- Strong relationships with physicians and referral sources
- Established infrastructure for in-home service delivery
- Focus on improving patient outcomes and reducing hospital readmissions
- Recurring revenue model
Weaknesses
- Reliance on Medicare and Medicaid reimbursement
- Geographic concentration in certain regions
- Potential for regulatory scrutiny and changes in reimbursement policies
- Competition from larger, more diversified healthcare companies
Opportunities
- Expansion into new geographic markets
- Development of new respiratory care services
- Partnerships with hospitals and healthcare systems
- Leveraging technology to improve patient monitoring and care coordination
- Acquisitions of smaller respiratory care providers
Threats
- Changes in Medicare and Medicaid reimbursement policies
- Increased competition from other home healthcare providers
- Economic downturn affecting patient access to care
- Rising labor costs and shortages of respiratory therapists
- Healthcare reform impacting the home healthcare industry
Competitors and Market Share
Key Competitors
- RMD
- PGNX
- AdaptHealth
Competitive Landscape
Viemed's advantages lie in its specialization in respiratory care and its relationships with physicians. Its disadvantages might be smaller scale compared to more diversified healthcare companies.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Viemed Healthcare Inc has grown through organic expansion and acquisitions.
Future Projections: Future growth projections depend on analyst forecasts, which are subject to change. Generally, future growth depends on expanding market penetration.
Recent Initiatives: Recent initiatives may include acquisitions, expansion into new geographic areas, and development of new services.
Summary
Viemed Healthcare Inc. is a player in the respiratory healthcare market, providing necessary at-home equipment and services. Its strong focus on respiratory therapy and improving patient outcomes are working in its favor. The dependency on Medicare and Medicaid could be a risk, alongside changes in healthcare regulation and the impact of market competition. Expansion opportunities and potential partnerships could drive future growth. Therefore, continuous management of the cost structure and competitive environment will be key to maintaining and increasing profitability.
Similar Companies
- RMD
- PGNX
- LHCG
Sources and Disclaimers
Data Sources:
- Company filings (where available)
- Industry reports
- Analyst estimates
- SEC.gov
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and based on available information. Actual results may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Viemed Healthcare Inc
Exchange NASDAQ | Headquaters Lafayette, LA, United States | ||
IPO Launch date 2017-12-22 | CEO & Director Mr. Casey Hoyt | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1179 | Website https://www.viemed.com |
Full time employees 1179 | Website https://www.viemed.com | ||
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.